Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
Universidad de Cantabria
Santander, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Cantabria (8)
2021
-
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis
Leukemia, Vol. 35, Núm. 1, pp. 245-249
2020
-
Multifaceted effects of soluble human CD6 in experimental cancer models
Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1
2017
-
ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA
Oncogene, Vol. 36, Núm. 12, pp. 1733-1744
2015
-
Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations
BMC Genomics, Vol. 16, Núm. 1
-
P-SMAD2/3 and DICER promote pre-miR-21 processing during pressure overload-associated myocardial remodeling
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1852, Núm. 7, pp. 1520-1530
-
Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes
Cancer Cell, Vol. 28, Núm. 2, pp. 170-182
2013
-
Cellular plasticity confers migratory and invasive advantages to a population of glioblastoma-initiating cells that infiltrate peritumoral tissue
Stem Cells, Vol. 31, Núm. 6, pp. 1075-1085
2011
-
Blockade of the NFκB pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo
Oncogene, Vol. 30, Núm. 32, pp. 3537-3548